CClinicalTrials.gg
CompletedNCT02236260ACUplusUpdated Sep 7, 2017

Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation

An interventional study of Electroacupuncture and Local Anesthesia (lidocaine hydrochloride) in Parkinson's Disease, sponsored by Nantes University Hospital. Completed at 1 site in France. Open to participants aged 18 Years to 74 Years. Per ClinicalTrials.gov, last updated 2017-09-07.

Sponsored by Nantes University Hospital · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 74 Years
Sex
All
01

Study summary

The effectiveness of Deep Brain Stimulation (DBS) in certain movement disorders is widely demonstrated. The success of this procedure requires that the patient is awake and cooperative. The conditions of this intervention can be difficult to tolerate by the patient for several reasons: long procedure (from 3 to 8 hours), body immobilisation (particularly the head in the stereotactic frame), stress related to the localization of the DBS. It is therefore important to improve the comfort as well as the cooperation of the patient, during implantation of the DBS electrodes, in order to optimize the conditions of the intervention. In addition to analgesia, acupuncture should allow sedation without affecting alertness and should contribute to the regulation of any vegetative reactions during the procedure. Therefore, we hypothesize that acupuncture could improve the quality of care of the patient during a DBS procedure. In practice, this is electroacupuncture that will be used in this research to maintain the stimulation of acupuncture points to an optimal level during the time of the intervention.

02

Conditions studied

  • Parkinson's Disease

Browse trials for

03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 20 is below the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Nantes University Hospital is the lead sponsor of 825 studies on the registry; 195 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 74 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients from both sexes aged who are >= 18 years
  • Disabling movement disorders, resistant to medical treatment, in Parkinson's patients who should benefit from a Deep Brain Stimulation in the subthalamic nucleus
  • Scheduled intervention of a Deep Brain Stimulation
  • Understanding of acupunctural analgesia with electrostimulation
  • Signed informed consent
  • Membership to a social security insurance scheme

Exclusion criteria

Exclusion Criteria:

  • Patients who are >= 75 years
  • History of intolerance to acupuncture
  • Contraindications to local anesthesia
  • Respiratory problems (asthma, COPD, ...)
  • Holder of an implanted pacemaker
  • Obesity with BMI > 30
  • History of motion sickness
  • Unstabilized psychiatric disorders
  • Impaired cognitive functions
  • Pregnancy
  • Breastfeeding
  • Minors
  • Major under a legal protection regime
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Active comparator
    Local anesthesia alone

    Drug: Local Anesthesia (lidocaine hydrochloride)

  • Experimental
    Local Anesthesia + Electroacupuncture

    Procedure: Electroacupuncture · Drug: Local Anesthesia (lidocaine hydrochloride)

Interventions

  • ProcedureElectroacupuncture

    Acupuncture will be performed using an electrical stimulator (generating electrical stimulation) for electroacupuncture.

  • DrugLocal Anesthesia (lidocaine hydrochloride)

    All patients will receive injectable paracetamol for pain relief, a mix of nitrous oxide 50% and oxygen 50% for analgesia and lidocaine hydrochloride for local anesthesia.

06

What researchers measure

Primary outcomes

  1. Patient comfort, judged by "Edmonton Symptom Assessment System" scale (ESAS)

    Time frame: The day of the DBS procedure

Secondary outcomes

  1. Patient anxiety, judged by Hamilton anxiety scale (HAMA)

    Time frame: The day before the DBS procedure, the day of the DBS procedure, 2 days after the DBS procedure

  2. Drug consumption

    Time frame: The day of the DBS procedure, 2 days after the DBS procedure

  3. Anesthesia monitoring parameters: heart rate, blood pressure, pulse oximetry

    Composite measure

    Time frame: The day of the DBS procedure, 2 days after the DBS procedure

  4. Adverse effects

    Time frame: The day before the DBS procedure,the day of the DBS procedure, 2 days after the DBS procedure

07

Study locations

1 site
  • Centre Hospitalier Universitaire de Nantes
    Nantes, 44000, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 7, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02236260
Lead sponsor
Nantes University Hospital
Responsible party
Sponsor
First posted
Sep 10, 2014
Start date
Sep 3, 2014
Primary completion
Jun 12, 2017
Completion
Jun 14, 2017
Last update
Sep 7, 2017

Study contacts

Sylvie RAOUL, MD
principal investigator · Nantes University Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion